Back to Search
RONALD WILDER, M.D.
M.D.
Rheumatology Physician
NPI: 1740304617Individual
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
M27517(MD)
Research & Publications (20)
Genetic factors involved in central nervous system/immune interactions.
PMID 11727781·Adv Exp Med Biol·2001
6-review
Susceptibility to autoimmune disease and drug addiction in inbred rats. Are there mechanistic factors in common related to abnormalities in hypothalamic-pituitary-adrenal axis and stress response function?
PMID 11268408·Ann N Y Acad Sci·2000
6-review
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
PMID 11920511·Cancer·2002
8-other
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
PMID 11920535·Cancer·2002
3-trial
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases.
PMID 12379637·Ann Rheum Dis·2002
6-review
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
PMID 11857290·Cancer·2002
8-other
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
PMID 12115338·Cancer·2002
8-other
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
PMID 11728680·Int J Radiat Oncol Biol Phys·2001
8-other
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
PMID 11163493·Int J Radiat Oncol Biol Phys·2001
8-other
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.
PMID 11395243·Int J Radiat Oncol Biol Phys·2001
3-trial
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
PMID 11413536·Cancer·2001
8-other
Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
PMID 10955856·Am J Clin Oncol·2000
8-other
A prospective study of intrafraction prostate motion in the prone vs. supine position.
PMID 19679405·Int J Radiat Oncol Biol Phys·2010
8-other
Early exposure to anesthesia and learning disabilities in a population-based birth cohort.
PMID 19293700·Anesthesiology·2009
4-observational
North Carolina dental hygiene students' opinions about tobacco cessation education and practices in their programs.
PMID 19433529·J Dent Educ·2009
8-other
Differences in static and dynamic measures in evaluation of talonavicular mobility in gait.
PMID 19648718·J Orthop Sports Phys Ther·2009
8-other
Periodontal-systemic disease education in U.S. and Canadian dental schools.
PMID 19126766·J Dent Educ·2009
8-other
Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort.
PMID 19602960·Anesthesiology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10319 WESTLAKE DR STE 213
BETHESDA, MD 20817 - Phone
- (252) 586-7968
Quick Facts
- NPI
- 1740304617
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile